Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56076 - 56100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	DUSP10	11221	upregulated	panobinostat results in increased expression of DUSP10 mRNA	1q41	A21037
Panobinostat	Approved Investigational	DUSP4	1846	downregulated	panobinostat results in decreased expression of DUSP4 mRNA	8p12	A21037
Panobinostat	Approved Investigational	DUSP5	1847	upregulated	panobinostat results in increased expression of DUSP5 mRNA	10q25.2	A21037
Panobinostat	Approved Investigational	DYNC1I1	1780	upregulated	panobinostat results in increased expression of DYNC1I1 mRNA	7q21.3	A21037
Panobinostat	Approved Investigational	E2F2	1870	downregulated	panobinostat results in decreased expression of E2F2 mRNA	1p36.12	A21037
Panobinostat	Approved Investigational	EBF1	1879	upregulated	panobinostat results in increased expression of EBF1 mRNA	5q33.3	A21037
Panobinostat	Approved Investigational	EDN1	1906	upregulated	panobinostat results in increased expression of EDN1 mRNA	6p24.1	A21037
Panobinostat	Approved Investigational	EDNRA	1909	upregulated	panobinostat results in increased expression of EDNRA mRNA	4q31.22-q31.23	A21037
Panobinostat	Approved Investigational	EDNRB	1910	upregulated	panobinostat results in increased expression of EDNRB mRNA	13q22.3	A21037
Panobinostat	Approved Investigational	EFNA1	1942	upregulated	panobinostat results in increased expression of EFNA1 mRNA	1q22	A21037
Panobinostat	Approved Investigational	EFNA5	1946	downregulated	panobinostat results in decreased expression of EFNA5 mRNA	5q21.3	A21037
Panobinostat	Approved Investigational	EGF	1950	downregulated	panobinostat results in decreased expression of EGF mRNA	4q25	A21037
Panobinostat	Approved Investigational	EGFL8	80864	upregulated	panobinostat results in increased expression of EGFL8 mRNA	6p21.32	A21037
Panobinostat	Approved Investigational	EIF3M	10480	downregulated	panobinostat results in decreased expression of EIF3M mRNA	11p13	A21037
Panobinostat	Approved Investigational	EIF4E3	317649	downregulated	panobinostat results in decreased expression of EIF4E3 mRNA	3p13	A21037
Panobinostat	Approved Investigational	ELF1	1997	upregulated	panobinostat results in increased expression of ELF1 mRNA	13q14.11	A21037
Panobinostat	Approved Investigational	ELF3	1999	upregulated	panobinostat results in increased expression of ELF3 mRNA	1q32.1	A21037
Panobinostat	Approved Investigational	ELF5	2001	upregulated	panobinostat results in increased expression of ELF5 mRNA	11p13	A21037
Panobinostat	Approved Investigational	ELK3	2004	upregulated	panobinostat results in increased expression of ELK3 mRNA	12q23.1	A21037
Panobinostat	Approved Investigational	ELMOD1	55531	upregulated	panobinostat results in increased expression of ELMOD1 mRNA	11q22.3	A21037
Panobinostat	Approved Investigational	ELOVL2	54898	downregulated	panobinostat results in decreased expression of ELOVL2 mRNA	6p24.2	A21037
Panobinostat	Approved Investigational	ELP4	26610	downregulated	panobinostat results in decreased expression of ELP4 mRNA	11p13	A21037
Panobinostat	Approved Investigational	EMILIN3	90187	downregulated	panobinostat results in decreased expression of EMILIN3 mRNA	20q12	A21037
Panobinostat	Approved Investigational	EMP1	2012	upregulated	panobinostat results in increased expression of EMP1 mRNA	12p13.1	A21037
Panobinostat	Approved Investigational	ENPP2	5168	upregulated	panobinostat results in increased expression of ENPP2 mRNA	8q24.12	A21037

Displaying entries 56076 - 56100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability